Observational study assesses hospital mortality risks in COVID-19 patients, suggesting RDW is not a key predictor.
Objective: To investigate if red blood cell distribution width (RDW) is a risk factor for hospital mortality in patients admitted to a public university hospital in Belo Horizonte, Minas Gerais, Brazil. Methods: This observational prospective study included patients over 16 years who had been hospitalized for COVID‐19 between May and October 2020. A descriptive and time‐to‐death analysis was performed using the Cox proportional hazards model. Results: Of the 161 patients included, 39 (24.2%) died during hospitalization. A total of 2227 blood counts were performed, an average of 13.8 tests per patient (standard deviation, SD 2.9). Upon admission, the RDW was normal (11.5% to 14.6%) in 115 patients (71.4%), elevated in 45 (28%), and low in 1 (0.6%). The mean RDW value at admission was 14.5 (SD 2.4), which falls within the normal reference range. Of the patients with normal RDW at admission, 82 (71.3%) maintained normal levels throughout their stay, while 33 (28.7%) showed increased RDW levels over time. Among those with elevated RDW at admission, 40 (88.9%) remained elevated, while 5 (11.1%) returned to normal levels. There was no significant difference in the mean RDW value at admission between survivors and nonsurvivors (14.4 [SD 2.4] for survivors vs. 14.9 [SD 2.4] for nonsurvivors; p = 0.2081). The risk for mortality in the group with high RDW upon admission was higher than in the group with normal RDW, but without statistical significance (31.1% vs. 21.7%; RR = 1.43; p = 0.413). When performing a multivariate analysis, the following continue to be risk factors for lower survival: age > 70 years, HR 4.8 (95% CI: 2.3; 10.3), p < 0.001; white race, HR 3.2 (95% CI: 1.2; 8.61), p = 0.018; and need for invasive MV, HR 3.8 (1.7; 8.7), p = 0.001. The presence of a chest X‐ray suggestive of COVID‐19, HR 3.5 (95% CI: 1.0; 11.5), p = 0.044, also appears to be a risk factor in this analysis. Conclusion: Alterations on RDW values on admission were not associated with higher mortality, and further increases in RDW during hospitalization were not linked to a higher risk of mortality across all age groups. Our findings suggest that while RDW may indicate disease severity, it may not serve as a reliable independent predictor of mortality when other factors are accounted for in this cohort.
No takes yet. Share an insight, caveat, or question.
Duani et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: